Anti Microbial Resistance Marker Sepsis Panel Meningitis/Encephalitis PCR panel Tropical Fever PCR Panel HPV Detection and Genotyping Panels Veterinary PCR Diagnostic Kit
Anti Microbial Resistance Marker Sepsis Panel Meningitis/Encephalitis PCR panel Tropical Fever PCR Panel HPV Detection and Genotyping Panels Veterinary PCR Diagnostic Kit

RT-PCR Detection of Ehrlichia canis in Dogs: A Molecular Approach to Early Diagnosis of Canine Ehrlichiosis

RT-PCR Detection of Ehrlichia canis in Dogs Tick-borne diseases represent a major challenge in veterinary medicine, affecting millions of dogs worldwide. Among these infections, Ehrlichia canis is one of the most significant bacterial pathogens responsible for Canine Monocytic Ehrlichiosis (CME). Early and accurate detection is essential to prevent disease progression and ensure effective treatment. Molecular diagnostics, particularly Real-Time PCR (RT-PCR), have emerged as one of the most reliable tools for detecting Ehrlichia canis in canine blood samples. What is Ehrlichia canis? Ehrlichia canis is an intracellular bacterium transmitted primarily by the brown dog tick (Rhipicephalus sanguineus). The pathogen infects monocytes, leading to systemic infection in dogs. Common clinical signs include: • Fever • Lethargy • Loss of appetite • Bleeding disorders • Enlarged lymph nodes • Thrombocytopenia If untreated, the disease may progress to chronic ehrlichiosis, which can be fatal. Limitations of Traditional Diagnostic Methods Conventional diagnostic methods such as microscopy and serology may have limitations: Microscopy • Low sensitivity • Requires experienced interpretation Serology • Cannot distinguish between past and active infection These limitations highlight the importance of molecular detection methods. Advantages of RT-PCR for Ehrlichia canis Detection RT-PCR provides a highly sensitive and specific method for detecting pathogen DNA directly from clinical samples. Key advantages include: ✔ Early detection before antibody production ✔ High analytical sensitivity ✔ Specific pathogen identification ✔ Rapid turnaround time This makes PCR an essential tool for veterinary diagnostic laboratories and surveillance programs. ANIDX Veterinary RT-PCR Kit for Ehrlichia canis To address the growing need for reliable veterinary molecular diagnostics, Retro Biotech has developed the ANIDX™ Veterinary RT-PCR Kit for Canine Ehrlichia canis Detection. The kit is designed for rapid, sensitive, and user-friendly molecular testing. Key Features • Ready-to-use Lyophilized PCR strip format • Minimal preparation and simplified workflow • High sensitivity detection of Ehrlichia canis • Compatible with open qPCR platforms • Designed for canine blood samples The lyophilized format provides improved reagent stability and makes the assay suitable for laboratories with varying workflow capacities. Applications The ANIDX Ehrlichia RT-PCR kit is suitable for: Veterinary diagnostic laboratories Animal hospitals and clinics Veterinary research institutions Tick-borne disease surveillance programs Strengthening Veterinary Molecular Diagnostics With increasing prevalence of vector-borne diseases, there is a growing need for reliable molecular diagnostics in veterinary medicine. At Retro Biotech, we are committed to developing innovative PCR solutions that enable accurate, scalable, and accessible testing for animal health. Through the ANIDX – Next-Gen Testing for Animals platform, we aim to support veterinarians, diagnostic laboratories, and researchers in improving disease detection and animal healthcare outcomes. ???? Learn more about veterinary PCR kits: https://retrobiotech.in/veterinary_pcr_diagnostic_kit If you want, I can also generate: • 3 more SEO blogs for ANIDX veterinary testing • A full Veterinary PCR pillar page for RetroBiotech SEO • Top Google keywords for veterinary PCR kits (to rank faster) • Blog image/banner design prompt for Canva matching your LinkedIn post.reposting from my profileHere is a clean repost caption for your personal LinkedIn profile (Aditya Sharma) when sharing the post from the Retro Biotech page. Personal reposts usually perform better when they sound more conversational and founder-driven. Pleased to share a new addition from Retro Biotech’s veterinary diagnostics portfolio. Tick-borne diseases like Ehrlichia canis continue to impact canine health globally, making early and reliable detection essential for effective treatment and surveillance. Through our ANIDX – Next-gen Testing for Animals initiative, we are working to develop molecular diagnostic solutions specifically tailored for veterinary applications. Our Veterinary RT-PCR Kit for Canine Ehrlichia canis Detection features: ???? Lyophilized strip format for simplified workflow ???? Designed for canine blood samples ⚡ Rapid & sensitive molecular detection ???? Compatible with open qPCR platforms Solutions like these aim to make veterinary molecular testing more accessible to diagnostic labs, veterinary clinics, and research institutions. Proud of the team at Retro Biotech continuing to push innovation across One Health diagnostics. #VeterinaryDiagnostics #AnimalHealth #VeterinaryPCR #Ehrlichiosis #OneHealth #RetroBiotech #ANIDX If you want, I can also write a more viral-style repost (higher engagement) that tends to get 2–3× more reach on LinkedIn founders’ profiles.more viral-style repost (higher engagement) shorterHere is a shorter, higher-engagement repost style (better for LinkedIn algorithm and founder profiles): ???? Tick-borne diseases remain a major challenge in canine health. Excited to share that Retro Biotech is expanding its veterinary molecular diagnostics with the ANIDX™ RT-PCR Kit for Ehrlichia canis detection. ???? Lyophilized PCR strip format ⚡ Rapid & sensitive detection ???? Open qPCR platform compatible A small step toward making advanced molecular diagnostics more accessible for veterinary labs and clinics. Proud of the team pushing innovation under the One Health vision. #VeterinaryDiagnostics #AnimalHealth #VeterinaryPCR #Ehrlichiosis #ANIDX #RetroBiotech #OneHealth If you'd like, I can also give you a “LinkedIn algorithm booster version” (3 lines + hook format) that often performs even better for reach and impressions.yesHere is the LinkedIn algorithm booster version (very high reach style). This format works well because it uses a hook + short lines + whitespace, which increases read time and engagement. ???? Tick-borne diseases are still widely underdiagnosed in dogs. Yet early detection can completely change treatment outcomes. At Retro Biotech, we are working to make veterinary molecular diagnostics more accessible. Introducing the ANIDX™ RT-PCR Kit for Ehrlichia canis. ???? Lyophilized PCR strip format ⚡ Rapid & sensitive detection ???? Compatible with open qPCR systems A small step forward for faster veterinary diagnostics and better animal health. #AnimalHealth #VeterinaryDiagnostics #VeterinaryPCR #Ehrlichiosis #ANIDX #RetroBiotech #OneHealth ???? Pro tip for reach: When you repost, add one question in the first comment like: How common is canine ehrlichiosis in your region? This helps boost LinkedIn engagement and impressions.

read more

Sepsis & Septic Shock: Why Rapid Molecular Detection Is Critical for Saving Lives

Sepsis is a life-threatening medical emergency caused by the body’s overwhelming and dysregulated response to infection. When not identified and treated early, sepsis can rapidly progress to septic shock, multi-organ failure, and death. Globally, sepsis remains one of the leading causes of mortality in intensive care units—particularly in neonates, immunocompromised patients, and critically ill adults. At Retro Biotech, we believe that early, accurate, and comprehensive pathogen detection is central to improving sepsis outcomes and strengthening antimicrobial stewardship through advanced molecular diagnostics. What Is Sepsis? Sepsis occurs when an infection triggers a systemic inflammatory response, leading to tissue damage, impaired blood flow, and organ dysfunction. Common sources include: Bloodstream infections Pneumonia Urinary tract infections Abdominal and soft tissue infections Without rapid intervention, sepsis can escalate to septic shock, characterized by persistent hypotension, lactic acidosis, and organ failure. Why Early Diagnosis Matters in Sepsis Traditional blood culture–based diagnostics, while considered a reference method, have well-recognized limitations: Long turnaround time (24–72 hours or more) Reduced sensitivity due to prior antibiotic exposure Limited ability to rapidly detect polymicrobial infections No early insight into antimicrobial resistance (AMR) mechanisms In contrast, multiplex real-time PCR (qPCR) enables simultaneous detection of multiple pathogens and resistance markers within ~60 minutes, supporting early clinical decision-making and targeted therapy. Retro Biotech’s Molecular Approach to Sepsis Detection Retro Biotech has developed advanced multiplex qPCR panels for sepsis research and surveillance workflows. These assays are designed to provide broad microbial coverage, AMR insight, and workflow efficiency for modern laboratories. Sepsis and AMR Detection Kit (RUO) The Sepsis and AMR Detection Kit (RUO) is a high-plex, open-system real-time PCR assay designed for research-based detection of bloodstream infection–associated pathogens and antimicrobial resistance markers. Key Features Detection coverage: 17 bacterial pathogens 3 fungal pathogens 11 antimicrobial resistance genes 8 multiplex reaction mixes with four dye channels (FAM, SUN, Cy5, TxRed) Integrated Exogenous Extraction Control (EEC) to monitor extraction and PCR performance Designed for polymicrobial sepsis profiling Compatible with major open qPCR platforms (Bio-Rad CFX96/384, Applied Biosystems QuantStudio, ABI 7500 Fast Dx) Estimated run time: ~60 minutes This panel supports research applications involving pathogen surveillance, AMR profiling, and molecular epidemiology of sepsis, enabling faster insights compared to conventional methods. Advantages of Multiplex qPCR in Sepsis Research Speed: Results within hours instead of days Breadth: Simultaneous detection of bacteria, fungi, and AMR genes Sensitivity: Effective even with low microbial load Stewardship support: Early AMR insight reduces empirical broad-spectrum antibiotic use Scalability: Suitable for high-throughput and surveillance studies Applications Across Healthcare & Research Settings Hospital-based sepsis research programs AMR surveillance and epidemiological studies ICU and NICU infection profiling Evaluation of rapid diagnostic workflows Comparative studies versus culture-based methods Commitment to Simplified Molecular Diagnostics At Retro Biotech, our mission is to make complex molecular testing simpler, faster, and more accessible. Our sepsis panels reflect this philosophy by combining robust assay design, multiplex efficiency, and open-platform compatibility, supporting laboratories as they move toward rapid, actionable molecular insights. Early detection saves lives. Molecular precision guides therapy.

read more

Tropical Fever Panel – Early PCR Diagnosis in LMICs

Tropical Fever Panel: Early Diagnosis Saves Lives in LMICs A Growing Challenge Tropical fevers—from dengue and malaria to scrub typhus and enteric fever—continue to threaten public health in low- and middle‑income countries (LMICs) like India, where diagnostic delays often lead to severe outcomes. A study in southern India showed high prevalence among febrile illnesses: Scrub typhus: 47.5% Malaria: 17.1% Enteric fever: 8% Dengue: 7% Indian Journal of Critical Care Medicine+3PMC+3PMC+3ACTM+5PMC+5IJID Online+5 In another cohort, nearly 38% of undifferentiated fever cases had undetermined causes—highlighting the need for better diagnostic tools ACTM+1. WHO Calls for Action The World Health Organization (WHO) has recently emphasized the urgent need for updated clinical guidelines for arboviral diseases like dengue, chikungunya, Zika, and yellow fever—underscoring the importance of early medical intervention World Health Organization+2Nature+2. Furthermore, WHO’s South-East Asia region, which includes India, remains highly endemic for dengue; robust public health systems are vital to reduce severe disease through timely diagnosis, proper referral, and case management World Health Organization. Globally, dengue has doubled in burden over the past few decades—from ~26 million cases in 1990 to nearly 59 million in 2021, with deaths rising from ~14,300 to ~29,000 journals.plos.org. Why Early & Accurate Diagnosis Matters Symptom overlap: Dengue, typhoid, scrub typhus, and malaria often present similarly—making clinical diagnosis imprecise PubMed. Syndromic management frameworks have been recommended in India to close these diagnostic gaps using rapid testing and algorithms PubMed. Reducing misuse of antibiotics is essential to combat the growing threat of antimicrobial resistance (AMR) in LMICs. PCR: A Game-Changer in Disease Detection Multiplex qPCR shines in accuracy and speed: Detects pathogen DNA/RNA with high sensitivity, even in early stages. Simultaneously targets multiple pathogens, ideal for complex tropical presentations. Delivers faster results, enabling prompt, targeted treatment. Reduces unnecessary empirical therapy, supporting WHO’s AMR goals. Retro Biotech’s Role in Transforming Diagnosis Retro Biotech is bridging the diagnostic gap with: Tropical Fever Multiplex Panels—pre-mixed OSR (Open System Reagents) for major tropical pathogens, including viruses, bacteria, and parasites. Compatibility with affordable, widely-used platforms (e.g., Quant Studio, 7500 Fast Dx, Bio-Rad CFX series). Tube-based kits simplifying workflow—no extraction hassles, fast turnaround. Kits engineered for LMIC labs: scalable, cost-effective, and robust. By supporting early detection with PCR, Retro Biotech aligns with WHO and national health priorities to reduce morbidity, optimize treatment, and limit outbreaks.

read more

Transforming Bovine Mastitis Diagnosis with Molecular PCR Technology

Bovine mastitis remains one of the costliest diseases in the dairy sector, causing up to 70% of total economic losses due to decreased milk yield, poor quality, and treatment expenses. Globally, mastitis affects 20–40% of dairy cows annually, with subclinical cases often going undetected for weeks, leading to disease spread and antimicrobial resistance (AMR) buildup. Limitations of Conventional Mastitis Detection Methods Traditional diagnostic approaches—such as California Mastitis Test (CMT), electrical conductivity checks, and visual milk or udder changes—are: ✅ Cost-effective and simple, suitable for routine herd screening. ❌ Indirect, often leading to false positives or false negatives (Figure 1). ❌ Unable to identify the causative pathogen, limiting targeted treatment. ❌ Resulting in broad-spectrum antibiotic use, contributing to AMR emergence. Recent studies show that over 60% of mastitis cases involve mixed bacterial infections, where empirical treatment often fails, prolonging infection cycles. The AMR Challenge in Bovine Mastitis Whole Genome Sequencing (WGS) of mastitis milk samples has revealed: >50 bacterial species associated with mastitis, including high-prevalence pathogens such as: Pseudomonas stutzeri Streptococcus agalactiae Pseudomonas aeruginosa Klebsiella pneumoniae Over 40 distinct AMR genes frequently detected, such as: qnr, mecA, tetA, ermB, and sul1, conferring resistance to beta-lactams, aminoglycosides, tetracyclines, and fluoroquinolones. Studies indicate 70–80% of mastitis isolates are resistant to at least one antibiotic class, making treatment less effective. RetroPCR Advantage: Pathogen & AMR Gene Detection in One Test Retro Biotech’s Direct-to-PCR (D2P) Mastitis Panel overcomes conventional diagnostic limitations by delivering: Multiplex PCR detection of 15+ major mastitis pathogens directly from raw milk. AMR gene profiling, identifying genetic resistance markers in <1 hour. No DNA extraction required, reducing errors and handling time. Portable field-use PCR setup, enabling on-farm decision-making. This allows precision veterinary treatment, replacing empirical broad-spectrum antibiotic use with pathogen-specific therapy, minimizing AMR risk, and improving herd health. Impact on Dairy Productivity Early, accurate diagnosis reduces disease spread in the herd. Optimized antimicrobial stewardship, reducing drug costs and milk discard periods. Improved milk quality and yield, enhancing farmer profitability. Alignment with One Health initiatives, reducing AMR transmission risks from animals to humans. Conclusion Mastitis management must evolve beyond outdated screening tools toward real-time molecular diagnostics. With RetroPCR, dairy farms and veterinary labs can achieve: Rapid pathogen identification AMR resistance gene detection Precision treatment strategies This shift is vital for sustainable dairy farming, reduced economic losses, and global AMR containment.

read more

Zoonotic Diseases and Antimicrobial Resistance: The Growing Human Health Threat

Nearly 60% of all human infectious diseases are zoonotic in origin, meaning they are transmitted from animals to humans. Among these, a significant number harbor antimicrobial resistance genes (ARGs)—genetic elements that allow bacteria to withstand antibiotic treatment. This silent but escalating crisis threatens not only human health but also the sustainability of modern medicine. ???? The Link Between Zoonotic Diseases and AMR Zoonotic diseases originate from a variety of sources—wildlife, livestock, and even domestic pets. When pathogens jump from animals to humans, they often bring along a package of resistance genes acquired from decades of antibiotic exposure in agriculture, veterinary medicine, or the environment. ScienceDirect studies highlight that livestock farming—especially in high-density settings—acts as a breeding ground for drug-resistant pathogens such as Salmonella, Campylobacter, and E. coli. PMC and Frontiers reports confirm that ARGs can be transferred through direct animal contact, contaminated food, water, or even shared environments, leading to infections in humans that are harder and costlier to treat. According to zoonotic-diseases.org, the rise of multi-drug resistant bacteria in both humans and animals is now recognized as a “One Health” challenge, demanding cross-sector collaboration. ⚠️ Why This Matters Higher Mortality Rates: Resistant zoonotic infections are often severe, requiring longer hospital stays and stronger, more toxic drugs. Global Spread: International travel and trade make resistant pathogens a worldwide issue, not just a local concern. Future Pandemics: Experts warn that unchecked antimicrobial use in animals increases the risk of a drug-resistant outbreak with pandemic potential. ???? The One Health Approach To break this cycle, a One Health framework is essential—integrating human, animal, and environmental health to track and control AMR: Responsible Antibiotic Use: Reducing non-therapeutic use of antibiotics in livestock. Surveillance and Diagnostics: Rapid molecular detection of resistant pathogens across humans and animals. Environmental Stewardship: Managing waste from farms and hospitals to limit ARG spread. ???? Retro Biotech’s Role At Retro Biotech, we are committed to strengthening AMR surveillance and diagnostics through direct-to-PCR molecular testing platforms. Our assays and customized panels help: Detect zoonotic pathogens and their resistance markers rapidly, without complex lab workflows. Support One Health initiatives by enabling field-deployable, point-of-care testing for both human and veterinary applications. Empower public health authorities with real-time data to track and contain resistant infections before they spread. ✅ Call to Action AMR is not just a clinical issue—it’s an ecosystem problem. Limiting its impact requires collaboration among clinicians, veterinarians, farmers, researchers, and policymakers. ???? Learn more about our Zoonotic Disease & AMR Diagnostic Solutions at www.retrobiotech.in or reach out to us for custom panel design tailored to your surveillance needs. References: ScienceDirect: Zoonotic origins of infectious diseases and ARG transmission. PMC: AMR gene transfer from animals to humans. Frontiers: One Health strategies to curb zoonotic AMR spread. zoonotic-diseases.org: Global zoonotic pathogen tracking.

read more